Latest news
Loading news…
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
RayzeBio was acquired by Bristol-Myers Squibb in 2023.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
119
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- San Diego, California, United States
- Diversity spotlight
- Women Founded
Key People at RayzeBio
Chief Medical Officer
Scientific Founder, Chief Technology Officer, Advisor
119
professional contacts at RayzeBio
Contact execs at RayzeBio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to RayzeBio
Loading news…
FAQs about RayzeBio
People who checked this page also checked these
Browse the full Acquirezy directory.